Caladrius Biosciences Inc... (CLBS)
NASDAQ: CLBS
· Real-Time Price · USD
0.43
-0.08 (-16.05%)
At close: Sep 15, 2022, 6:00 AM
Caladrius Biosciences Revenue Breakdown
| Period Ending | Dec 31, 2016 |
|---|---|
| PCT Segment Revenue | 35.27M |
| PCT Segment Revenue Growth | n/a |
| R&D Segment Revenue | 14K |
| R&D Segment Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2012 |
|---|---|
| Regenerative Medicine - China Segment Revenue | 52.3K |
| Regenerative Medicine - China Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.48M | 3.34M | 2.7M | 2.84M | 2.82M | 3.01M | 2.54M | 2.32M | 2.47M | 2.56M | 2.31M | 2.07M | 2.36M | 2.55M | 2.29M | 2.06M | 2.15M | 2.9M | 2.67M | 2.94M | 3.43M | 5.95M | 4.27M | 4.94M | 4.71M | 6.46M | 5.03M | 5.15M | 8.74M | 11.09M |
| Selling, General, and Administrative Revenue Growth | +4.16% | +23.82% | -5.07% | +0.89% | -6.38% | +18.55% | +9.39% | -6.18% | -3.28% | +10.50% | +11.94% | -12.30% | -7.67% | +11.60% | +11.01% | -3.96% | -25.89% | +8.55% | -9.33% | -14.27% | -42.30% | +39.19% | -13.41% | +4.90% | -27.13% | +28.29% | -2.20% | -41.08% | -21.21% | n/a |
| Research and Development Revenue | 3.24M | 3.28M | 4.15M | 4.13M | 4.33M | 5.08M | 2.91M | 3.03M | 1.82M | 1.5M | 2.77M | 3M | 2.99M | 2.04M | 1.51M | 1.7M | 2.12M | 2.26M | 4.65M | 3.19M | 4.28M | 3.46M | 2.57M | 2.63M | 4.03M | 5.88M | 3.18M | 6.32M | 7.6M | 6.8M |
| Research and Development Revenue Growth | -1.19% | -21.01% | +0.61% | -4.71% | -14.72% | +74.61% | -4.03% | +66.61% | +21.28% | -45.83% | -7.89% | +0.54% | +46.61% | +35.16% | -11.37% | -19.85% | -6.17% | -51.37% | +45.97% | -25.50% | +23.53% | +34.55% | -2.16% | -34.69% | -31.45% | +84.84% | -49.66% | -16.91% | +11.72% | n/a |